Of note, platelet microvesicles effectively delivered miR-223 to lung cancer cells and promoted cancer cell invasion by reducing Erythrocyte Membrane Protein Band 4.1-like 3 (EPB41L3) levels [82]. The gene discussed is EPB41L3; the disease is lung carcinoma.